Mutations in carboxy-terminal part of E2 including PKR/eIF2alpha phosphorylation homology domain and interferon sensitivity determining region of nonstructural 5A of hepatitis C virus 1b: their correlation with response to interferon monotherapy and viral load

World J Gastroenterol. 2006 Jun 21;12(23):3722-8. doi: 10.3748/wjg.v12.i23.3722.

Abstract

Aim: To study the amino acid substitutions in the carboxy (C)-terminal part of E2 protein and in the interferon (IFN) sensitivity determining region (ISDR) and their correlation with response to IFN and viral load in 85 hepatitis C virus (HCV)-1b-infected patients treated with IFN.

Methods: The C-terminal part of E2 (codons 617-711) including PKR/eIF2alpha phosphorylation homology domain (PePHD) and ISDR was sequenced in 85 HCV-1b-infected patients treated by IFN monotherapy.

Results: The amino acid substitutions in PePHD detected only in 4 of 85 patients were not correlated either with response to IFN or with viral load. The presence of substitutions in a N-terminal variable region (codons 617-641) in the C-terminal part of E2 was significantly correlated with both small viral load (33.9% vs 13.8%, P = 0.0394) and sustained response to IFN (25.0% vs 6.9%, P = 0.0429). Four or more substitutions in ISDR were significantly correlated with both small viral load (78.6% vs 16.2%, P < 0.0001) and sustained response to IFN (85.7% vs 2.9%, P < 0.0001). In multivariate analysis, ISDR in nonstructural (NS) 5A (OR = 0.39, P < 0.0001) and N-terminal variable region (OR = 0.51, P = 0.039) was selected as the independent predictors for small viral load, and ISDR (OR = 39.0, P < 0.0001) was selected as the only independent predictor for sustained response.

Conclusion: The N-terminal variable region in the C-terminal part of E2 correlates with both response to IFN monotherapy and viral load and is one of the factors independently associated with a small viral load.

MeSH terms

  • Adult
  • Aged
  • Amino Acid Sequence
  • Amino Acid Substitution
  • Antiviral Agents / therapeutic use*
  • Codon / analysis
  • Codon / genetics
  • DNA, Viral / analysis
  • DNA, Viral / genetics
  • Female
  • Hepacivirus / chemistry
  • Hepacivirus / genetics*
  • Hepacivirus / pathogenicity
  • Hepacivirus / physiology
  • Hepatitis C / drug therapy*
  • Humans
  • Interferons / therapeutic use*
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Molecular Sequence Data
  • Multivariate Analysis
  • Mutation / genetics
  • Phosphorylation
  • Protein Structure, Tertiary / genetics*
  • Sequence Homology, Amino Acid
  • Treatment Outcome
  • Viral Envelope Proteins / analysis
  • Viral Envelope Proteins / chemistry
  • Viral Envelope Proteins / genetics*
  • Viral Load*
  • eIF-2 Kinase / analysis
  • eIF-2 Kinase / chemistry
  • eIF-2 Kinase / genetics*

Substances

  • Antiviral Agents
  • Codon
  • DNA, Viral
  • Viral Envelope Proteins
  • glycoprotein E2, Hepatitis C virus
  • Interferons
  • eIF-2 Kinase